Horizon Discovery Group (HZD)

 

Latest News

Horizon development agreement with Roche Diagnostics

orizon Discovery Grouhas entered into an agreement with Roche Diagnostics to assist in the development of immunohisto...

Agreement with Roche Diagnostics

RNS Number: 5776Z Horizon Discovery Group plc 18 December 2017 Horizon Discovery enters into agreement with Roche Diagnostics to support the development of immunohistochemistry assays for oncology Horizon to develop and manufacture FFPE Reference Standards that express NTRK fusion biomarkers Standards to be derived from custom gene edited cel...

Horizon and ERS Genomics extend licence agreement

Horizon Discovery Group and ERS Genomics have announced the extension of their pre-existing non-exclusive, worldwide...

HZD expand CRISPR license rights with ERS Genomics

RNS Number: 3618Y Horizon Discovery Group plc 05 December 2017 Horizon extends industry-leading gene editing IP portfolio through expansion of CRISPR license rights with ERS Genomics Breadth of research use rights now expanded to include multiple new species Grant of rights to have products made and sold by partners Grant of sub-licensed rights to one s...

All News

DateHeadlineSource
18-12-17Horizon development agreement with Roche DiagnosticsStockMarketWire
18-12-17Agreement with Roche DiagnosticsRNS
05-12-17Horizon and ERS Genomics extend licence agreement StockMarketWire
05-12-17HZD expand CRISPR license rights with ERS GenomicsRNS
24-11-17Total Voting RightsRNS
18-10-17Four experts aged 27-54 reveal how they're investing their pensionMoney Observer
03-10-17Total Voting RightsRNS
29-09-17Best AIM companies of 2017 Interactive Investor
26-09-17Horizon sees significant improvement in margins StockMarketWire
26-09-17Interim ResultsRNS
25-09-17Holdings in CompanyRNS
18-09-17Neil Woodford's trades in August 2017Interactive Investor
08-09-17Broker Forecast - Numis issues a broker note on Horizon Discovery Group PlcStockMarketWire
08-09-17Horizon in line with guidance StockMarketWire
08-09-17Trading UpdateRNS
04-09-17Holding(s) in CompanyRNS
04-09-17Holding(s) in CompanyRNS
31-08-17Completion of AcquisitionRNS
24-08-17Holding(s) in CompanyRNS
24-08-17Holding(s) in CompanyRNS
23-08-17Horizon set co complete GE Healthcare Dharmacon dealStockMarketWire
23-08-17Completion of PlacingRNS
22-08-17Update on Acquisition of GE Healthcare DharmaconRNS
07-08-17All resolutions passed at GM of Horizon DiscoveryStockMarketWire
07-08-17Result of General MeetingRNS
07-08-17Director/PDMR ShareholdingRNS
24-07-17Block Listing ApplicationRNS
20-07-17Broker Forecast - RBC Capital Markets issues a broker note on Horizon Discovery Group PlcStockMarketWire
19-07-17Horizon to acquire DharmaconStockMarketWire
19-07-17Acquisition and Proposed Placing to Raise ?80mRNS
07-07-17Additional ListingRNS
04-07-17Holdings in CompanyRNS
03-07-17Horizon reference standards support FDA filing StockMarketWire
03-07-17Reference Standards support successful FDA filingRNS
28-06-17Horizon Discovery shareholders pass all resolutions at AGMStockMarketWire
28-06-17Result of AGMRNS
26-06-17Holding(s) in CompanyRNS
16-06-17Additional ListingRNS
15-06-17Broker Forecast - N+1 Singer issues a broker note on Horizon Discovery Group PlcStockMarketWire
06-06-17Additional ListingRNS

RSS feeds

  • Editorial news feed for LSE:HZD Editorial
  • Regulatory news feed for LSE:HZD Regulatory

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account